• Senzer's inhaler delivers cannabinoids faster at lower doses biospectrumasia
    September 29, 2018
    Insys holds the license to use Senzer's device to deliver the cannabinoid, Dronabinol, in the US and the trial is part of its goal to achieve regulatory approval from the U.S. Food and Drug Administration.
PharmaSources Customer Service